Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Abmart
company
About
Abmart specializes in antibody customization and antibody-related services.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥20M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 22, 2007
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥20M
Abmart has raised a total of
¥20M
in funding over 2 rounds. Their latest funding was raised on
Jun 12, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 12, 2018 | Series B | ¥20M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Abmart is funded by 2 investors.
Puming Dianli Xitong Gongcheng
and Unity Asset Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Unity Asset Management
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
